Barclays Maintains Overweight on Bruker, Lowers Price Target to $45
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and lowers the price target from $50 to $45.
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and lowers the price target from $50 to $45.